AbbVie ABBV reported its Q3 earnings results on Friday, October 28, 2022 at 07:44 AM.
Here's what investors need to know about the announcement.
Earnings
AbbVie beat estimated earnings by 1.95%, reporting an EPS of $3.66 versus an estimate of $3.59.
Revenue was up $470.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 4.17% drop in the share price the next day.
Here's a look at AbbVie's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 3.33 | 3.14 | 3.28 | 3.22 |
EPS Actual | 3.37 | 3.16 | 3.31 | 3.33 |
Revenue Estimate | 14.62B | 13.63B | 14.98B | 14.32B |
Revenue Actual | 14.58B | 13.54B | 14.89B | 14.34B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
AbbVie management provided guidance for FY 2022, expecting earnings between $13.76 and $13.96 per share.
To track all earnings releases for AbbVie visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.